Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001493152-26-045582

Options or other derivatives

  • Director acquired 55,924 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Macfarlane K. Angela Director 2026-10-01 Grant or award · Stock Options (right to buy) +55,924 55,924 D
Loading xslF345X06/ownership.xml…